Lauching Of The Lebanese National Strategic Plan To End TB For 2023-2030

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
J01DC02	AXETINE	G	Cefuroxime sodium - 1.5g	1.5g	Injectable powder for solution	2,273,782 L.L
J01DC04	CECLOR	B	Cefaclor (monohydrate) - 250mg/5ml	250mg/5ml	Granules for suspension	851,100 L.L
J01DC04	CLORACEF FORTE	G	Cefaclor (monohydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	632,950 L.L
J01DC04	CECLOR MR	B	Cefaclor (monohydrate) - 500mg	500mg	Tablet, film coated, modified release	1,226,096 L.L
J01DC04	CECLOR MR	B	Cefaclor (monohydrate) - 750mg	750mg	Tablet, film coated, modified release	1,555,018 L.L
J01DC04	CECLOR	B	Cefaclor (monohydrate) - 125mg/5ml	125mg/5ml	Granules for suspension	487,623 L.L
J01DC10	CEFPROZ	G	Cefprozil - 500mg	500mg	Tablet, film coated	1,737,588 L.L
J01DC10	CEFPROZ 250	G	Cefprozil - 250mg/5ml	250mg/5ml	Powder for suspension	712,237 L.L
J01DC10	CEFPROZ 250	G	Cefprozil - 250mg/5ml	250mg/5ml	Powder for suspension	1,343,843 L.L
J01DD01	CEFOTAX	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	217,702 L.L
J01DD01	CEFOTAXIME PANPHARMA	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution	6,127,922 L.L
J01DD01	CLAFOCARE	G	Cefotaxime (sodium) - 1g	1g	Injectable powder for solution	8,031,731 L.L
J01DD01	STOPAREN	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	213,671 L.L
J01DD02	CEFTAZIDIME PANPHARMA	G	Ceftazidime (pentahydrate) - 1g	1g	Injectable powder for solution	3,300,477 L.L
J01DD02	FORTECARE	G	Ceftazidime - 1g	1g	Injectable powder for solution	10,011,695 L.L
J01DD02	NEGACEF	G	Ceftazidime (pentahydrate) - 1g	1g	Injectable dry powder for solution	4,421,242 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution	3,455,595 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	433,869 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	403,153 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	403,153 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution	3,455,595 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	MEDAXONUM	G	Ceftriaxone (disodium) (Vial) - 500mg, Lidocaine (ampoule) -	500mg	Injectable powder for solution+diluent	307,740 L.L
J01DD04	MEGION-A	G	Ceftriaxone - 0.5g/2ml, Lidocaine (ampoule) -	0.5g/2ml	Injectable powder + solvent	355,840 L.L
J01DD04	TRIAXONE	G	Ceftriaxone (sodium) - 500mg	500mg	Injectable powder for solution+diluent	356,118 L.L
J01DD04	ROCEPHIN IV	B	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	757,927 L.L
J01DD04	ROCEPHIN IM	B	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	731,050 L.L